Quick answer
Insomnia often travels with depression and can keep it from improving. The American College of Physicians recommends cognitive behavioral therapy for insomnia (CBT-I) as the first treatment for chronic insomnia, with medication considered if CBT-I alone isn't enough. Treating sleep directly is a legitimate part of resistant-depression care.
If you’re in crisis right now: call or text 988 (Suicide & Crisis Lifeline) or call 911.
Key Takeaways
- Insomnia and depression feed each other, and treating one can help the other.
- Chronic insomnia means trouble sleeping at least three nights a week for three months or more.
- CBT-I is the recommended first treatment for chronic insomnia.
- Sleep medications have a limited, usually short-term role, weighed case by case.
Why does insomnia matter in resistant depression?
Insomnia matters because poor sleep worsens mood, energy and concentration, and can make an otherwise helpful antidepressant look like it isn’t working. Treating sleep directly removes an obstacle. This guide is part of our series on treatment-resistant depression in New York.
Chronic insomnia is trouble sleeping that causes distress or impairment and happens at least three nights a week for at least three months.1
Other causes to check
Before assuming insomnia is just part of depression, it’s worth checking other causes. The ACP notes that secondary causes such as depression, pain, substance use and other sleep disorders like sleep apnea and restless legs should be considered.1 Some antidepressants also affect sleep, so timing and choice of medication matter.
What is CBT-I, and why is it first-line?
CBT-I is a structured treatment that combines changing unhelpful thoughts about sleep with behavioral methods like sleep restriction and stimulus control, plus sleep education. The ACP recommends it as the initial treatment for chronic insomnia, and notes it can be delivered individually, in groups, by phone or online, or through self-help books.1
For long-standing low mood, see chronic depression vs. TRD.
How do insomnia treatment options compare?
Treatment follows a general order, adjusted to your situation.
| Option | Role |
|---|---|
| CBT-I | Recommended first treatment for chronic insomnia |
| Adjusting antidepressant timing or choice | Reduces medication-related sleep problems |
| Treating other sleep disorders | Sleep apnea or restless legs may need their own care |
| Sleep medications | Considered if CBT-I alone isn’t enough, usually short-term |
The ACP notes FDA-approved insomnia medications are meant for short-term use.1 Some sleep medications are controlled substances, which in New York means an I-STOP check before prescribing.4
What good care looks like
Good care for resistant depression asks why earlier treatment fell short, then chooses the next step on purpose. Here is how that plays out for this situation.
Sleep left untreated
Depression treatment changes again and again while insomnia quietly keeps symptoms going.
Treat sleep on purpose
Insomnia is assessed on its own terms, other causes checked, and CBT-I made part of the plan.
Better nights, clearer progress
As sleep improves, it becomes easier to see whether depression treatment is working.
Common myths, and what the evidence says
Myth: Insomnia will go away when the depression does.
Fact: Sometimes, but insomnia often persists and deserves its own treatment.
Myth: Sleeping pills are the main treatment for insomnia.
Fact: The ACP recommends CBT-I first, with medication considered if CBT-I alone isn’t enough.1
Myth: CBT-I requires months of weekly sessions.
Fact: It can be delivered in several formats, including phone, web-based modules and self-help books.1
What the first 90 days usually look like
Care moves in steps, and each change is checked before the next one. Your timing may differ, and that’s normal.
Assess sleep
A sleep history, a short sleep log and a check for other causes like sleep apnea.
Start CBT-I
A referral or resource for CBT-I, with antidepressant timing adjusted if needed.
Review both
Sleep and mood tracked together, with other options considered if sleep doesn't improve.
Ready to talk it through with a psychiatrist?
Schedule nowInsomnia and depression care in New York
Adults who are physically in New York State can be seen by secure video, and CBT-I is available in several formats that work well alongside video care.1 The practice lists Aetna and Cigna as in-network plans; confirm your plan’s network status for New York care before booking. Self-pay patients receive a superbill and a written good faith estimate.
Questions to ask at your first visit
A clear plan starts with a few direct questions. Bring these with you.
- Could insomnia be holding back my depression treatment?
- Should I be checked for sleep apnea?
- Is my antidepressant affecting my sleep?
- How can I access CBT-I?
- Is there a role for sleep medication for me?
The bottom line
When insomnia persists, depression often can't fully lift. For New York adults, treating sleep directly, starting with CBT-I, can be the step that makes the rest of treatment work.
Frequently Asked Questions
Can insomnia make depression harder to treat?
Yes. Poor sleep worsens mood, energy and concentration, and it can make an antidepressant look ineffective. Treating insomnia directly removes that obstacle and makes it easier to judge whether depression treatment is working. It's a legitimate part of resistant-depression care, not a side issue. Tracking sleep alongside mood makes that easier to see.
What is CBT-I?
CBT-I, cognitive behavioral therapy for insomnia, combines changing unhelpful thoughts about sleep with behavioral methods such as sleep restriction and stimulus control, plus sleep education. The American College of Physicians recommends it as the initial treatment for chronic insomnia, and it can be delivered individually, in groups, by phone or online.
Are sleeping pills a good idea with depression?
Sleep medications can have a limited role, but the ACP recommends CBT-I first, with medication considered if CBT-I alone isn't enough. FDA-approved insomnia medications are meant for short-term use. Some are controlled substances, which in New York means an I-STOP check. Your psychiatrist will weigh the trade-offs with you.
Could something else be causing my insomnia?
Possibly. Pain, substance use, other sleep disorders like sleep apnea or restless legs, and some medications can all disrupt sleep. The ACP recommends considering these secondary causes. An evaluation can help identify them and point you toward the right care. A sleep study may be suggested if symptoms point that way.
Can my antidepressant cause insomnia?
Some antidepressants can affect sleep, especially if taken later in the day. Changing the timing or the medication can help. Tell your psychiatrist when you take each dose and how your sleep has changed since starting, so adjustments can be made carefully. A short sleep log for a week gives your psychiatrist the detail needed to adjust timing.
Can insomnia be treated by video in New York?
Yes. Adults who are physically in New York State can be evaluated by secure video, and CBT-I is available in formats that fit well with video care, including web-based programs. A simple sleep log is one of the most useful things to bring. Bring any wearable or app sleep data too, if you use one, though a written log is usually enough.
How We Reviewed This Page
This page draws on primary sources including federal agencies (FDA, CDC, HRSA, USPSTF), South Carolina law and state agency notices, ACOG clinical practice guidelines and peer-reviewed research. It was written by Steven Lockhart and is pending clinical review by Gabriella I. Farkas, MD PhD, a board-certified psychiatrist licensed in South Carolina and New York. We review it at least every 180 days or when FDA labeling or clinical guidance changes.
What’s new: September 2026. Page published. Clinical review by Dr. Farkas pending before this page is marked reviewed.
References
- American College of Physicians. ACP Recommends Cognitive Behavioral Therapy as Initial Treatment for Chronic Insomnia (Qaseem A, et al. Ann Intern Med. 2016;165:125–133). May 3, 2016. https://www.acponline.org/node/296994
- U.S. Food and Drug Administration (via Healthcare Purchasing News). FDA Approves New Nasal Spray Medication for Treatment-Resistant Depression. March 7, 2019. https://www.hpnonline.com/home/article/13001954/fda-approves-new-nasal-spray-medication-for-treatment-resistant-depression
- New York State Department of Health. Electronic Prescribing: Mandatory Electronic Prescribing Effective March 27, 2016. Accessed September 2026. https://healthweb-back.health.ny.gov/professionals/narcotic/electronic_prescribing/
- New York State Department of Health. PMP/I-STOP: Prescription Monitoring Program, Internet System for Tracking Over-Prescribing. Accessed September 2026. https://healthweb-back.health.ny.gov/professionals/narcotic/prescription_monitoring/